Growth Metrics

Humana (HUM) Receivables - Other (2016 - 2025)

Humana has reported Receivables - Other over the past 17 years, most recently at $159.0 million for Q4 2025.

  • Quarterly results put Receivables - Other at $159.0 million for Q4 2025, down 4.79% from a year ago — trailing twelve months through Dec 2025 was $159.0 million (down 4.79% YoY), and the annual figure for FY2025 was $159.0 million, down 4.79%.
  • Receivables - Other for Q4 2025 was $159.0 million at Humana, down from $167.0 million in the prior quarter.
  • Over the last five years, Receivables - Other for HUM hit a ceiling of $1.3 billion in Q4 2021 and a floor of $159.0 million in Q4 2025.
  • Median Receivables - Other over the past 5 years was $173.0 million (2023), compared with a mean of $399.2 million.
  • Biggest five-year swings in Receivables - Other: soared 578.35% in 2021 and later tumbled 86.25% in 2022.
  • Humana's Receivables - Other stood at $1.3 billion in 2021, then tumbled by 86.25% to $181.0 million in 2022, then decreased by 4.42% to $173.0 million in 2023, then fell by 3.47% to $167.0 million in 2024, then fell by 4.79% to $159.0 million in 2025.
  • The last three reported values for Receivables - Other were $159.0 million (Q4 2025), $167.0 million (Q4 2024), and $173.0 million (Q4 2023) per Business Quant data.